Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Padua
Clinical trial register · Italy

Clinical Trials in Padua, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sanofi9 Genzyme, a Sanofi Company3 University of Padova3 AstraZeneca3 Istituto Oncologico Veneto IRCCS2
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Padua

50 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
AstraZeneca
Phase 2
80
Meldola, Milan, Padua, Ravenna, Rome, Torino
2026-06-04
Recruiting
Incyte Corporation
Phase 2
60
Bologna, Genova, Monza, Padua, Pavia, Rome
2026-05-20
Recruiting
Transition to KPL-387 Monotherapy Dosing & Administration Study
NCT07288216Recurrent Pericarditis, Heart Diseases, Pericarditis
DrugKPL-387
Kiniksa Pharmaceuticals International, plc
Phase 2
120
Florence, Genoa, Milan, Padua, Udine, Varese
2026-03-25
Recruiting
AstraZeneca
Phase 2
124
Milan, Padua, Roma, Rozzano
2026-02-10
Recruiting
Incyte Corporation
Phase 3
250
Bologna, Brescia, Catania, Milan, Naples, Padua, Roma, Rome
2025-11-13
Recruiting
Sanofi
Phase 2
54
Milan, Padua, Rome, Turin
2025-10-14
Recruiting
Intent of Surgery for IPMN
NCT07216521Intraductal Papillary Mucinous Neoplasm
NYU Langone Health
Observational
2,000
Milan, Padua
2025-09-15
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Florence, Genova, Milan, Naples, Padua, Perugia, Rome, Rozzano
2025-09-08
Recruiting
Ocus Innovation Ireland Limited
Phase 3
234
Bari, Milan, Padua
2025-09-01
Recruiting
University of Padova
Observational
563
Padua
2025-08-13
Recruiting
Kiniksa Pharmaceuticals International, plc
Phase 2/3
325
Florence, Genoa, Milan, Padua, Turin, Udine, Varese
2025-07-25
Recruiting
University of Padova
Not applicable
46
Padua
2025-06-16
Active, closed
Swedish Orphan Biovitrum
Phase 4
252
Catania, Padua, Salerno, Turin
2025-05-21
Recruiting
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
NCT06708299Recurrent Pericarditis
Cardiol Therapeutics Inc.
Phase 3
110
Milan, Padua, Torino, Udine
2025-04-07
Active, closed
Sanofi
Phase 2
204
Genoa, Milan, Rozzano, Naples, Padua, Rome, Turin, Alessandria
2025-03-28
Active, closed
Sanofi
Phase 3
231
Cona, Florence, Genoa, Milan, Padua, Rome, Bologna
2025-02-12
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
51
Rozzano, Padua, Turin
2025-01-22
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830Parkinson Disease, Parkinson, Idiopathic Parkinson Disease, Early Parkinson Disease (Early PD)
Neuron23 Inc.
Phase 2
150
Milan, Naples, Padua, Pisa, Rome
2025-01-17
Active, closed
Sanofi
Phase 2
260
Milan, Rozzano, Padua, Rome, Pisa
2024-12-10
Active, closed
AstraZeneca
Phase 3
181
Bologna, Catania, Florence, Padua, Pisa, Roma, Rozzano
2024-12-03
Recruiting
Comparative Analysis of fast-and Slow-absorbable Poly(Lactose-co-glycolide) Sutures in Oral Surgery: a Randomized Controlled Trial.
NCT07498361Poly(Lactide-co-glycolide) Sutures, Suture Resorption, Third Molar Surgery
University of Padova, School of Dental Medicine
Not applicable
27
Padua
2024-12-03
Active, closed
Sanofi
Phase 2
229
Milan, Padua, Pisa
2024-08-29
Recruiting
Sanofi
Phase 3
160
Milan, Rozzano, Padua, Bologna
2024-08-21
Recruiting
Bristol-Myers Squibb
Phase 1/2
224
Milan, Padua, Verona
2024-07-17
Recruiting
University Hospital Padova
Not applicable
580
Padua
2024-06-01
Recruiting
University of Padova
Not applicable
70
Padua
2024-05-15
Recruiting
CarThera
Phase 3
560
Bologna, Livorno, Padua, Roma, Rozzano, Torino
2024-01-29
Recruiting
Casa Sollievo della Sofferenza IRCCS
Phase 2
30
San Giovanni Rotondo, Novara, Padua, Palermo
2024-01-25
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsErbitux·Cetuximab
AVEO Pharmaceuticals, Inc.
Phase 3
410
Bologna, Florence, Milan, Novara, Padua, Pavia, Roma
2024-01-11
By invitation
Sanofi
Phase 3
90
Milan, Padua, Rome, Naples, Pavia
2024-01-03
Recruiting
EXO Biologics S.A.
Phase 1/2
265
Florence, Genova, Milan, Modena, Padua
2023-12-28
Recruiting
Sanofi
Phase 3
180
Milan, Padua, Palermo, Pavia, Siena
2023-10-10
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction
Institut für Pharmakologie und Präventive Medizin
Observational
250
Ancona, Bologna, Brescia, Florence, Milan, Padua, Pisa, Roma
2023-09-05
Recruiting
Ospedali Riuniti Ancona
Not applicable
150
Ancona, Padua
2023-01-16
Recruiting
Octapharma
Phase 3
38
Bergamo, Milan, Padua, Roma
2022-07-01
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma, Myelodysplastic Syndromes
DrugsAzoles·Gilteritinib·Azacitidine·Venetoclax
Sumitomo Pharma America, Inc.
Phase 1/2
606
Bologna, Busto Arsizio, Genoa, Meldola, Padua, Perugia, Ravenna, Rome
2022-02-28
Active, closed
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
NCT05059262Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Diffuse
DrugVimseltinib
Deciphera Pharmaceuticals, LLC
Phase 3
123
Bologna, Milan, Naples, Padua, Rome
2021-10-14
Active, closed
Daiichi Sankyo
Phase 3
490
Barone, Candiolo, Catanzaro, Milan, Modena, Naples, Padua, Pisa
2021-05-21
Recruiting
IFOM ETS - The AIRC Institute of Molecular Oncology
Observational
500
Genova, Milan, Padua, Pisa, Candiolo, Orbassano, Torino
2020-10-28
Active, closed
Institut de Recherches Internationales Servier
Phase 3
331
Turin, Bologna, Padua, Roma, Rozzano
2020-01-05
Active, closed
Sanofi
Observational
1,860
Terracina, Naples, Padua, Bari, Bologna, Brescia, Catania, Milan
2019-08-15
Active, closed
Università Vita-Salute San Raffaele
Not applicable
2,000
Cotignola, Catania, Lecce, Milan, Padua, Pisa, Potenza, Rome
2019-04-15
Recruiting
Study of Individuals Affected With Hypoplasminogenemia
NCT03797495Plasminogen Deficiency
Indiana Hemophilia &Thrombosis Center, Inc.
Observational
100
Milan, Padua
2018-12-18
Active, closed
Istituto Oncologico Veneto IRCCS
Observational
121
Padua
2017-11-01
Active, closed
The GOLD Study: G8 in OLDer Patients
NCT03449914Elderly Metastatic Colorectal Cancer Patients
Istituto Oncologico Veneto IRCCS
Observational
109
Padua
2017-10-26
Active, closed
Exelixis
Phase 4
247
Catania, Roma, Siena, Pisa, Milan, Padua, Torino
2015-02-25
Recruiting
Arrhythmias Detection in a Real World Population
NCT02275637Appropriate and Inappropriate Shock Therapy With ICD, Arrhythmias Detection
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
10,000
Bergamo, Bologna, Catania, Florence, Milan, Naples, Padua, Pavia
2014-09
Recruiting
Pompe Pregnancy Sub-Registry
NCT00567073Glycogen Storage Disease Type II (GSD-II), Pompe Disease (Late-onset), Glycogenesis 2 Acid Maltase Deficiency
Genzyme, a Sanofi Company
Observational
20
Florence, Milan, Padua, Rome, Brescia, Cagliari, Genova, Messina
2007-06-18
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Gussago, Cona, Florence, Milan, Padua, Rome, Brescia, Cagliari
2004-09-15
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Florence, Milan, Baggiovara, Monza, Padua, Rome, Bassano del Grappa, Bologna
2001-07-31
Rows per page Showing 1–50 of 50
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/padua

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 50 of those studies with a site in Padua.

How many clinical trials are recruiting in Padua?

34 of the 50 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 15 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Padua), 50 studies
PhaseStudiesRecruitingShare
Phase 315930%
Observational12924%
Phase 210720%
Not applicable6512%
Phase 1/2438%
Phase 4204%
Phase 2/3112%

Most active sponsors

Lead sponsors with the most studies (Padua)
Lead sponsorStudiesRecruiting
Sanofi93
AstraZeneca32
Genzyme, a Sanofi Company33
University of Padova33
Incyte Corporation22
Institut de Recherches Internationales Servier20
Istituto Oncologico Veneto IRCCS20
Kiniksa Pharmaceuticals International, plc22
Arcus Biosciences, Inc.11
AVEO Pharmaceuticals, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.